|
|||||
       |
Poplar plants produced from a gene-editing experiment at University of Georgia, left, had red-colored wood compared to the original green. Red stem is a known side effect of lignin modification. (University of Georgia) 5 June 2015. Plant scientists at University of Georgia used an emerging technique for gene editing to modify the genomes . . . → Read More: Gene Editing Modifies Tree Genomes to Reduce Lignin  Comments are closed  New products  agriculture, biofuels, biotechnology, genomics, life sciences, university (bfishadow, WikimediaCommons) 4 June 2015. Innovation Economy Corporation is going public by skipping the usual route of hiring an investment bank, and instead will use crowdfunding to attract investors to its initial public offering of stock. The Riverside, California enterprise, that goes by the trade name ieCrowd, licenses life science and health-related technologies . . . → Read More: Life Sciences Commercialization Firm to Crowdfund IPO Comments are closed Finance biomedical, crowdfunding, engineering, entrepreneurs, equity, investment, IPO, licensing, medical device, nanotechnology (National Institutes of Health) 4 June 2015. A clinical trial of an immune system therapy shows one treatment reduces levels of harmful immune activity and joint inflammation in people with rheumatoid arthritis. The early-stage trial led by researchers at University of Queensland in Brisbane, Australia is reported yesterday in the journal Science Translational . . . → Read More: Trial Shows Immunotherapy Reduces Rheumatoid Arthritis One comment - (Comments are closed) New products, Regulations Australia, biomedical, biotechnology, clinical trials, entrepreneurs, licensing, life sciences, pharmaceuticals, university (Centers for Disease Control and Prevention) 3 June 2015. Auspherix Limited, a start-up developer of new antibiotic drugs, raised £6 million ($US 9.2 million) in early-stage venture financing. Funding for the two year-old enterprise, located in a pharmaceutical and biotechnology incubator at Stevenage, U.K., was led by technology commercialization company Imperial Innovations plc, . . . → Read More: Antibiotic Developer Adds $9.2 Million in Early Funds One comment - (Comments are closed) Finance Australia, biomedical, chemistry, entrepreneurs, equity, Europe, investment, life sciences, pharmaceuticals, U.K., university, venture capital (General Electric Co.) 3 June 2015. Digital Manufacturing and Design Innovation Institute in Chicago is developing a technology platform to make it easier for manufacturing companies to share technical data with their customers and suppliers, adapting concepts proposed by General Electric, which was chosen to lead the project. The platform, known as digital . . . → Read More: GE, Institute to Design Digital Manufacturing Platform Comments are closed Joint ventures/collaborations, New products engineering, manufacturing, physical sciences, robotics, software, university (Centers for Disease Control and Prevention) 2 June 2015. Drug maker Astellas Pharma Inc. in Tokyo and Anokion SA, a biotechnology company in Lausanne, Switzerland, are forming Kanyos Bio Inc., a spin-off enterprise to develop therapy candidates for autoimmune diseases. The deal could bring Kanyos Bio, based in Cambridge, Massachusetts, as much as . . . → Read More: Spin-Off Biotech Formed for Autoimmune Disorders One comment - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations Asia, biomedical, biotechnology, entrepreneurs, equity, Europe, investment, Japan, licensing, life sciences, pharmaceuticals, venture capital (National Institute of General Medical Sciences, NIH) 2 June 2015. A new clinical trial will test 20 cancer drugs and drug combinations targeted to specific genetic mutations, regardless of cancer type. The study, known as NCI-Match is a joint project of National Cancer Institute, an agency of National Institutes of Health, and the . . . → Read More: Trial to Test Cancer Drugs Matched to Gene Mutations One comment - (Comments are closed) Joint ventures/collaborations, Regulations biomedical, cancer, clinical trials, genomics, life sciences, NIH, pharmaceuticals Mini gamma ray camera (University of Leicester) 1 June 2015. Physicists and medical researchers at two universities in the U.K. designed a hand-held camera that performs gamma ray imaging, normally requiring a powerful room-sized device for diagnosing tumors and other medical functions. The team from Universities of Leicester and Nottingham also formed a . . . → Read More: Mini Gamma Camera Developed, Spin-Off Company Formed One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, clinical trials, engineering, entrepreneurs, Europe, medical device, patent, physical sciences, physics, U.K., university, venture capital (National Cancer Institute) 1 June 2015. A late-stage clinical trial shows an engineered antibody that harnesses the immune system increases the survival time of people with a common form of lung cancer compared to standard chemotherapy. The study of the drug nivolumab, marketed as Opdivo by Bristol-Myers Squibb, was reported yesterday at the . . . → Read More: Antibody Improves Lung Cancer Survival Time in Trial Comments are closed Regulations biomedical, biotechnology, cancer, clinical trials, FDA, life sciences, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.